Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Abvc Biopharma (ABVC) Gross Profit (2016 - 2025)

Historic Gross Profit for Abvc Biopharma (ABVC) over the last 9 years, with Q3 2025 value amounting to $795950.0.

  • Abvc Biopharma's Gross Profit rose 10462.49% to $795950.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 million, marking a year-over-year increase of 25256.38%. This contributed to the annual value of $508826.0 for FY2024, which is 44010.84% up from last year.
  • Abvc Biopharma's Gross Profit amounted to $795950.0 in Q3 2025, which was up 10462.49% from $1966.0 recorded in Q4 2024.
  • In the past 5 years, Abvc Biopharma's Gross Profit registered a high of $795950.0 during Q3 2025, and its lowest value of -$137041.0 during Q4 2023.
  • For the 5-year period, Abvc Biopharma's Gross Profit averaged around $128779.3, with its median value being $31528.0 (2022).
  • In the last 5 years, Abvc Biopharma's Gross Profit crashed by 16733.18% in 2021 and then skyrocketed by 293306.63% in 2024.
  • Abvc Biopharma's Gross Profit (Quarter) stood at -$40595.0 in 2021, then surged by 897.1% to $323583.0 in 2022, then plummeted by 142.35% to -$137041.0 in 2023, then surged by 101.43% to $1966.0 in 2024, then soared by 40385.76% to $795950.0 in 2025.
  • Its Gross Profit was $795950.0 in Q3 2025, compared to $1966.0 in Q4 2024 and $388980.0 in Q3 2024.